Editor's Note: TheStreet ratings do not represent the views of TheStreet's staff or its contributors. Ratings are established by computer based on metrics for performance (which includes growth, stock performance, efficiency and valuation) and risk (volatility and solvency). Companies with poor cash flow or high debt levels tend to earn lower ratings in our model
Dow Jones Industrial Average
) is trading up 76 points (+0.5%) at 14,834 as of Friday, Jun 21, 2013, 9:35 a.m. ET. During this time, 192.9 million shares of the 30 Dow components have changed hands vs. an average daily trading volume of 597.5 million. The NYSE advances/declines ratio sits at 1,830 issues advancing vs. 437 declining with 120 unchanged.
- EXCLUSIVE OFFER: Jim Cramer's Protégé, Dave Peltier, only buys Stocks Under $10 that he thinks could potentially double. See what he's trading today with a 14-day FREE pass.
The Dow component leading the way higher looks to be
), which is sporting a 90-cent gain (+1.9%) bringing the stock to $47.21. This single gain is lifting the Dow Jones Industrial Average by 6.81 points or roughly accounting for 9% of the Dow's overall gain. Volume for Merck currently sits at 4.9 million shares traded vs. an average daily trading volume of 18.8 million shares.
Merck has a market cap of $143.67 billion and is part of the health care sector and drugs industry. Shares are up 13.1% year to date as of Thursday's close. The stock's dividend yield sits at 3.6%.
Merck & Co., Inc. provides various health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products worldwide. The company has a P/E ratio of 24.3, above the S&P 500 P/E ratio of 17.7.
TheStreet Ratings rates Merck as a
. The company's strengths can be seen in multiple areas, such as its largely solid financial position with reasonable debt levels by most measures, good cash flow from operations, expanding profit margins and solid stock price performance. We feel these strengths outweigh the fact that the company has had sub par growth in net income.
- You can view the full Merck Ratings Report.
Holding back the Dow today is
), which is lagging the broader Dow index with an 80-cent decline (-0.4%) bringing the stock to $196.54. Volume for International Business Machines currently sits at 2.5 million shares traded vs. an average daily trading volume of 4.2 million shares.
International Business Machines has a market cap of $223.91 billion and is part of the technology sector and computer software & services industry. Shares are up 3% year to date as of Thursday's close. The stock's dividend yield sits at 1.9%.
International Business Machines Corporation provides information technology (IT) products and services worldwide. The company operates in five segments: Global Technology Services, Global Business Services, Software, Systems and Technology, and Global Financing. The company has a P/E ratio of 14, below the S&P 500 P/E ratio of 17.7.
TheStreet Ratings rates International Business Machines as a
. The company's strengths can be seen in multiple areas, such as its notable return on equity, growth in earnings per share, expanding profit margins and increase in stock price during the past year. We feel these strengths outweigh the fact that the company has had generally high debt management risk by most measures that we evaluated.
- You can view the full International Business Machines Ratings Report.
STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.